Ryan Hallett

Ryan Hallett is an accomplished professional in the biotechnology sector with extensive experience in product development and management. Currently serving as Vice President of Product Development at Lanier Biotherapeutics and working as an Independent Consultant for Life Science Startups in the Southeast Region, Ryan also holds the position of Chief Executive Officer and Co-founder at Dualogics since December 2017, where expertise is utilized in creating bispecific antibody therapeutics through the OrthoMab platform. Ryan previously co-founded Dualogics LLC and contributed as Chief Operating Officer from February 2015 to December 2017. Early in the career, Ryan gained extensive research experience as a Postdoctoral Researcher and Graduate Research Assistant at the University of North Carolina at Chapel Hill and as a Research Technician at the University of Florida. Academic qualifications include a PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill and a B.S. in Chemistry with a focus on Biochemistry from the University of Florida.